SEC

Extensive searches of SEC.gov, major news (Reuters, CoinDesk, The Block), court records, and X posts through July 2026 confirm zero credible evidence or updates supporting the sensational 2024 allegations of money laundering, insider trading, accounting fraud, or compliance violations at Coinbase, Kraken, or MicroStrategy. Core enforcement actions were dismissed with prejudice in Feb-Mar 2025 under the new Crypto Task Force; a May 2025 NYT user metrics inquiry at Coinbase remains unresolved with no 2026 updates. MicroStrategy faces only private shareholder matters (one dismissed 2025) and no SEC actions. Task Force under Chief Counsel Taylor Lindman (appt. Feb 2026) focuses exclusively on rulemaking and industry input, not new probes. All original claims remain unverified and appear rooted in rumors or fabrication.

Since the March 19-20, 2026 DOJ indictment of SMCI affiliates for smuggling NVIDIA AI servers, new SEC Form 4 filings reveal additional NVIDIA insider sales on March 20 including Director Mark Stevens (221,682 shares), CFO Colette Kress ($10.9M), totaling part of a $14M wave under 10b5-1 plans, with no links to the SMCI case or illegal trading. SMCI stock rebounded 5% on March 23 after a 28-33% plunge, as the company cooperates and was not charged. No new SEC probes, unusual options remain speculative without confirmed insider ties, aligning with routine disposals amid market volatility.

2025 marked record-high lobbying expenditures by the pharmaceutical industry, with PhRMA spending nearly $38 million and total healthcare lobbying surging 16% to $653 million in the first three quarters, underscoring intensified influence amid regulatory shifts. Confirmed reverse revolving door appointments include Chainlink's Taylor Lindman as SEC Crypto Task Force Chief Counsel in February 2026 and Nancy Beck's ongoing senior role at EPA's chemical safety office; former Energy Secretary Jennifer Granholm expanded to Edison International's board alongside her DGA Group position. No major new forward revolving door placements for figures like ex-SEC Chair Gary Gensler as of March 2026, but the pattern persists with legislative efforts like H.R.3554 to curb it.